Title |
Review of the epidemiology of overactive bladder
|
---|---|
Published in |
Research and Reports in Urology, June 2016
|
DOI | 10.2147/rru.s102441 |
Pubmed ID | |
Authors |
Renu S Eapen, Sidney B Radomski |
Abstract |
Overactive bladder (OAB) is common in both men and women. It is a symptom complex that causes significant detriment to quality of life in patients. Although the prevalence of OAB is similar in both sexes, there are sex-specific differences in individual symptoms and the impact on quality of life. The coexistence of benign prostatic hyperplasia with OAB can worsen quality of life in men. This review examines the major studies that looked at the epidemiology of OAB as it relates to both sexes. It focuses on both the overall prevalence rates and the incidence of individual symptoms. This paper also addresses the level of bother and quality of life in men and women with OAB. In addition, the relationship between OAB and benign prostatic hyperplasia is reviewed. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
Costa Rica | 1 | 33% |
Unknown | 2 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 67% |
Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 194 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 35 | 18% |
Researcher | 28 | 14% |
Student > Postgraduate | 16 | 8% |
Student > Ph. D. Student | 11 | 6% |
Other | 11 | 6% |
Other | 35 | 18% |
Unknown | 58 | 30% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 58 | 30% |
Pharmacology, Toxicology and Pharmaceutical Science | 15 | 8% |
Biochemistry, Genetics and Molecular Biology | 9 | 5% |
Unspecified | 9 | 5% |
Nursing and Health Professions | 8 | 4% |
Other | 30 | 15% |
Unknown | 65 | 34% |